From GlobeNewswire: 2025-05-28 09:20:00

The Cell Therapy Human Raw Materials Market was valued at USD 2.9 billion in 2023 and is projected to reach USD 18.1 billion by 2032, with a CAGR of 22.6%. The market growth is driven by the demand for cell-based therapies and the need for high-quality raw materials to support therapeutic efficacy.

Advancements in biotechnology have increased the demand for raw materials like cell culture media, growth factors, and cryopreservation reagents. Personalized medicine and gene editing technologies are also contributing to the market growth, with companies ensuring a stable supply of critical components for cell therapy applications.

Major players in the market include Thermo Fisher Scientific, Lonza Group, Miltenyi Biotec, and Stemcell Technologies. North America dominates the market, while Asia Pacific is expected to be the fastest-growing region due to investments in biotechnology and cell therapy research.

The Cell Culture Media segment accounted for 40% of the market share in 2023, driven by the demand for specialized media for stem cell and CAR-T cell therapies. Biotechnology & Pharmaceutical Companies held the largest market share, emphasizing the need for reliable raw materials for research, clinical trials, and production.

Recent developments in the market include Thermo Fisher Scientific expanding its cell culture media portfolio, Lonza Group launching a new cryopreservation reagent, and Sartorius introducing a single-use bioreactor system for large-scale manufacturing of cell therapy raw materials. The global Cell Therapy Human Raw Materials Market is projected to grow at a CAGR of 22.6% from 2024 to 2032, driven by the increasing demand for cell-based therapies. Cell Culture Media holds the largest market share, with Biotechnology & Pharmaceutical Companies leading in end-use. North America leads, while Asia Pacific is the fastest-growing region.

The market is expected to reach $28.98 billion by 2032, with a CAGR of 22.55% through 2024-2032. Regenerative Medicine Market is forecasted to hit $235.98 billion by 2032 at a CAGR of 24.66%. Stem Cell Therapy Market is set to reach $1.11 billion by 2032, with a growth rate of 17.10%.

SNS Insider is a top market research and consulting agency providing clients with accurate market data, consumer insights, and opinions to make informed decisions. Using various techniques like surveys and focus groups worldwide, the company aims to equip clients with the knowledge needed to navigate changing market conditions.



Read more at GlobeNewswire: Cell Therapy Human Raw Materials Market Size to Reach USD